Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis.

Pharmaceuticals (Basel) · 2023 · PMC10674993 · PMID 38004378

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)

While metformin takers tended to score better on the UHDRS test, the result did not reach statistical significance ( p = 0.09) [ 34 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.